Real-world data on initial treatment strategies for older adult patients with endometrial cancer in Japan.

Mayu YunokawaShinsuke SasadaYae TakeharaKenta TakahashiTatsunori ShimoiKan YonemoriMitsuya IshikawaTomoyasu KatoKenji Tamura

Published in: Cancer chemotherapy and pharmacology (2019)

The results indicate that age 75 years and older might represent a cutoff for the development of age-based treatment strategies for endometrial cancer. This information could be used to determine the upper age limit for participation in clinical trials in Japan.

Keyphrases

endometrial cancer
clinical trial
physical activity
community dwelling
middle aged
electronic health record
healthcare
randomized controlled trial
machine learning
big data
artificial intelligence
open label